Lumos Pharma (LUMO) CFO Lawley gave up 229 shares at $1.79 to cover taxes or an exercise price
Insider transactions reported
Lori D Lawley (Chief Financial Officer at Lumos Pharma Inc., LUMO) reported that they gave up 229 shares at $1.79 to cover taxes or an exercise price on Aug 1, 2024. After these transactions the filing shows 12,284 shares held directly.
- Reporting person
- Lawley Lori D
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 1, 2024 | Shares withheld for taxes or exercise price (F) | Common Stock1, 2, 3, ... | -229 | $1.79 | $410 | 12,284 direct |
Holdings before and after
- Common Stock: 12,513 to 12,284 direct
Footnotes from the filing
- 1. Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 937 previously reported restricted stock units ( RSUs ) granted to the Reporting Person.
- 2. Includes 218 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- 3. Includes 938 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on August 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- 4. Includes 500 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- 5. Includes 750 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- 6. Includes 1,000 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on April 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Lawley report in this LUMO Form 4?
Lori D Lawley (Chief Financial Officer at Lumos Pharma Inc., LUMO) reported that they gave up 229 shares at $1.79 to cover taxes or an exercise price on Aug 1, 2024. After these transactions the filing shows 12,284 shares held directly.
How many LUMO shares does Lawley hold after this filing?
The filing shows 12,284 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for LUMO
Earlier insider filings at LUMO
- Jul 3, 2024Chief Medical Officer Pitukcheewanont Pisit Duke covered exercise/tax liability with 274 shares, decreasing direct ownership by 2% to 16,836 units (SEC Form 4)
- Jun 7, 2024SEC Form 4 filed by Van Es-Johansson An
- Jun 7, 2024SEC Form 4 filed by Mccracken Joseph S
- Jun 7, 2024SEC Form 4 filed by Johnson Chad Allen
- Jun 7, 2024SEC Form 4 filed by Zoth Lota S.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2011
Follow LUMO and get a push notification the moment its next story breaks.